<DOC>
	<DOCNO>NCT00744549</DOCNO>
	<brief_summary>The purpose study determine whether antioxidant ( vitamin E , selenium lycopene ) change ( reduce ) prostate tumor size blood flow prostate determine MRI image among men Active Surveillance .</brief_summary>
	<brief_title>Study Antioxidants MRI Detectable Early Stage Prostate Cancer Among Men Active Surveillance</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<criteria>MRI detectable prostate cancer PSA le 15 ng/ml Gleason score &lt; = 7 Prostate cancer stag T1c T2a Concurrent use highdose vitamin include selenium , lycopene , vitamin D vitamin E Other malignancy diagnose require treatment within past 5 year ( except superficial bladder cancer basal cell carcinoma ) Current use Proscar Avodart</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Male Urogenital Diseases</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Vitamin E</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Lycopene</keyword>
	<keyword>Selenium</keyword>
</DOC>